The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: A comparison with schizophrenic patients and healthy controls;O impacto da história de sintomas psicóticos na função cognitiva de doentes bipolares eutímicos: Comparação com doentes esquizofrênicos e controles saudáveis

Revista Brasileira de Psiquiatria

Volumn 33, Issue 4, 2011, Pages 353-361

  Brissos, Sofia ^a   Dias, Vasco Videira ^b,c   Soeiro de Souza, Márcio Gerhardt ^c   Balanzá Martínez, Vicent ^d,e   Kapczinski, Flavio ^f  

^a Clinical Neurophysiology Lab   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF VALENCIA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bipolar disorder; Neurobehavioral manifestations; Patients; Psychotic disorders; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOM;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84855815819     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462011000400008     Document Type: Article

References (41)

1. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res. 2004;71(2-3):405-16.
2. Daban C, Martinez-Arán A, Torrent C, Tabarés-Seisdedos R, Balanzá-Martínez V, Salazar-Fraile J, Selva-Vera G, Vieta E. Specificity of cognitive deficits in bipolar disorder versus schizophrenia: A systematic review. Psychother Psychosom. 2006;75(2):72-84.
3. Krabbendam L, Arts BM, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: A quantitative review. Schizophr Res. 2005;80(2-3):137-49.
4. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl. 2007;(434):17-26.
5. Balanzá-Martínez V, Tabares-Seisdedos R, Selva-Vera G, Martínez-Arán A, Torrent C, Salazar-Fraile J, Leal-Cercós C, Vieta E, Gómez-Beneyto M. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: A 3-year follow-up study. Psychother Psychosom. 2005;74(2):113-9.
6. Balanzá-Martínez V, Rubio C, Selva-Vera G, Martinez-Aran A, Sánchez-Moreno J, Salazar-Fraile J, Vieta E, Tabarés-Seisdedos R. Neurocognitive endophenotypes (Endophenocognitypes) from studies of relatives of bipolar disorder subjects: A systematic review. Neurosci Biobehav Rev. 2008;32(8):1426-38.
7. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disorder. 2006;8(2):103-16.
8. Martínez-Arán A, Vieta E, Colom F, Torrent C, Sánchez-Moreno J, Reinares M, Benabarre A, Goikolea JM, Brugué E, Daban C, Salamero M. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224-32.
9. Martínez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262-70.
10. Goes FS, Sanders LL, Potash JB. The genetics of psychotic bipolar disorder. Curr Psychiatry Rep. 2008;10(2):178-89.
11. Glahn DC, Bearden CE, Barguil M, Barrett J, Reichenberg A, Bowden CL, Soares JC, Velligan DI. The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry. 2007;62(8):910-16.
12. Reite M, Teale P, Rojas DC, Arciniegas D, Sheeder J. Bipolar disorder: anomalous brain asymmetry associated with psychosis. Am J Psychiatry. 1999;156(8):1159-63.
13. Sánchez-Morla EM, García-Jiménez MA, Barabash A, Martínez-Vizcaíno V, Mena J, Cabranes-Díaz JA, Baca-Baldomero E, Santos JL. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand. 2008;117(4):313-8.
14. Martin LF, Hall MH, Ross RG, Zerbe G, Freedman R, Olincy A. Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry. 2007;164(12):1900-6.
15. Albus M, Hubmann W, Wahlheim C, Sobizack N, Franz U, Mohr F. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand. 1996;94(2):87-93.
16. Bora E, Vahip S, Akdeniz F, Gonul AS, Eryavuz A, Ogut M, Alkan M. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord. 2007;9(5):468-77.
17. Glahn DC, Bearden CE, Cakir S, Barrett JA, Najt P, Serap Monkul E, Maples N, Velligan DI, Soares JC. Differential working memory impairment in bipolar disorder and schizophrenia: Effects of lifetime history of psychosis. Bipolar Disord. 2006;8(2):117-23.
18. Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ. Cognitive function in euthymic bipolar I disorder. Psychiatry Res. 2001;102(1):9-20.
19. Martinez-Arán A, Torrent C, Tabares-Seisdedos R, Salamero M, Daban C, Balanza-Martinez V, Sanchez-Moreno J, Manuel Goikolea J, Benabarre A, Colom F, Vieta E. Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry. 2008;69(2):233-9.
20. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry. 2003;64(1):86-93.
21. Goldberg TE, Gold JM, Greenberg R, Griffin S, Schulz SC, Pickar D, Kleinman JE, Weinberger DR. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry. 1993;150(9):1355-62.
22. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry. 2005;58(11):859-64.
23. Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, Bromet E. Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders. Schizophr Bull. 2009;35(5):1022-9.
24. Selva G, Salazar J, Balanzá-Martínez V, Martínez-Arán A, Rubio C, Daban C, Sánchez-Moreno J, Vieta E, Tabarés-Seisdedos R. Bipolar I patients with and without a history of psychotic symptoms: Do they differ in their cognitive functioning? J Psychiatr Res. 2007;41(3-4):265-72.
25. Szoke A, Meary A, Trandafir A, Bellivier F, Roy I, Schurhoff F, Leboyer M. Executive deficits in psychotic and bipolar disorders implications for our understanding of schizoaffective disorder. Eur Psychiatry. 2008;23(1):20-25.
26. Savitz J, van der Merwe L, Stein DJ, Solms M, Ramesar R. Neuropsychological status of bipolar I disorder: impact of psychosis. Br J Psychiatry. 2009;194(3):243-251.
27. Bora E, Yücel M, Pantelis C. Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study. J Affect Disord. 2010;127(1-3):1-9.
28. Brissos S, Dias V, Carita, Martinez-Arán A. Quality of Life in Bipolar Type I Disorder and Schizophrenia in Remission: Clinical and neurocognitive correlates. Psychiatry Res. 2008;160(1):55-62.
29. American Psychiatric Association-APA. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington; 1994.
30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(1):22-33.
31. Lezak M, Howienson D, Loring D. Neuropsychological assessment. Oxford University Press: Oxford; 2004.
32. Martinez-Arán A, Penades R, Vieta E, Colom F, Reinares M, Benabarre A, Salamero M, Gastó C. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom. 2002;71(1):39-46.
33. Goldberg JF. Adverse cognitive effects of psychotropic medications. In: Cognitive dysfunction in bipolar disorder: a guide for clinicians. Washington, DC: American Psychiatric Publishing; 2008. p.137-58.
34. Atre-Vaidya N, Taylor MA, Seidenberg M, Reed R, Perrine A, Glick-Oberwise F. Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11(3):120-26.
35. Ameen S, Ram D. Negative symptoms in the remission phase of bipolar disorder. German J Psychiatry. 2007;10(1):1-7.
36. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr Neuropsychological impairments in deficit vs nondefict forms of schizophrenia. Arch Gen Psychiatry. 1994;51(10):804-11.
37. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675-92.
38. Brockington IF, Hillier VF, Francis AF, Helzer JE, Wainwright S. Definitions of mania: concordance and prediction of outcome. Am J Psychiatry. 1983;140(4):435-39.
39. Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS, Rush AJ, Post RM. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry. 2003;44(4):263-69.
40. Goldstein JM, Seidman LJ, Goodman JM, Koren D, Lee H, Weintraub S, Tsuang MT. Are there sex differences in neuropsychological functions among patients with schizophrenia? Am J Psychiatry. 1998;155(10):1358-64.
41. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, Davidson M. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and non-psychotic bipolar disorder. Am J Psychiatry. 2002;159(12):2027-35.